The Metastatic Ability of Ewing's Sarcoma Cells Is Modulated by Stem Cell Factor and by Its Receptor c-kit
- 31 December 2000
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 157 (6), 2123-2131
- https://doi.org/10.1016/s0002-9440(10)64850-x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Engagement of CD99 Induces Apoptosis Through a Calcineurin-Independent Pathway in Ewing's Sarcoma CellsThe American Journal of Pathology, 1998
- Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirementOncogene, 1998
- Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidenceInternational Journal of Cancer, 1995
- Modulation of the Organ Microenvironment for Treatment of Cancer MetastasisJNCI Journal of the National Cancer Institute, 1995
- Ewingʼs sarcoma and peripheral primitive neuroectodermal tumorCurrent Opinion in Oncology, 1994
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplasmic tail.Genes & Development, 1992
- Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble formsCell, 1990
- Primary structure and functional expression of rat and human stem cell factor DNAsCell, 1990